Is there any upside left in DAWN stock as it soars 65%?
Day One Biopharmaceuticals (NASDAQ: DAWN) ripped higher on Friday morning after Servier signed a definitive agreement to acquire the California-based firm for about $2.5 billion in cash.Servier’s deal rewrites DAWN’s...


